GSK’s Pre-Pandemic Flu Vaccine To Get Priority Review In Japan
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Reflecting its growing concerns about new types of influenza outbreaks, Japan's Ministry of Health, Labor and Welfare will conduct a priority review of GlaxoSmithKline K.K.'s pre-pandemic vaccine, a GSK spokesman and ministry officials said Sept. 5